Postischemic Administration of Basic Fibroblast Growth Factor Improves Sensorimotor Function and Reduces Infarct Size Following Permanent Focal Cerebral Ischemia in the Rat
- 1 October 2002
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 177 (2), 531-537
- https://doi.org/10.1006/exnr.2002.7994
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Semirational design of a potent, artificial agonist of fibroblast growth factor receptorsNature Biotechnology, 1999
- The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regionsNeuroReport, 1999
- Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?Trends in Neurosciences, 1999
- To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents?Trends in Pharmacological Sciences, 1998
- Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the ratNeuroscience, 1998
- Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the ratJournal of the Neurological Sciences, 1996
- Delayed Treatment with Intravenous Basic Fibroblast Growth Factor Reduces Infarct Size following Permanent Focal Cerebral Ischemia in RatsJournal of Cerebral Blood Flow & Metabolism, 1995
- Growth Factors in StrokePublished by Springer Nature ,1995
- Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factorsCurrent Opinion in Neurobiology, 1994
- The Rotarod Test: An Evaluation of Its Effectiveness in Assessing Motor Deficits Following Traumatic Brain InjuryJournal of Neurotrauma, 1994